MORE►
Spectral AI
Spectral IP CEO Erich Spangenberg, left, and Spectral AI Founder and Chairman Dr. J Michael DiMaio [Photos: Spectral AI]
Dallas’ Spectral AI To Spin Off Spectral IP as Independent Public Company
by Lance Murray | Nov 6, 2024
Spectral AI, which focuses on medical diagnostics for faster and more accurate treatment decisions in wound care, said the spinoff aligns with its strategy to maximize shareholder value by fostering growth in its Spectral IP subsidiary. The spinoff will be renamed SIM IP and will be headquartered in Miami.
by Lance Murray |
Oct 18, 2024
Dr. J. Michael DiMaio, who founded the predictive AI company in 2009 and served as its CEO and chairman from 2011 to 2020, currently holds a chief of staff post at Baylor Scott & White.
MORE►
by Lance Murray |
May 31, 2024
Dallas-based artificial intelligence company Spectral AI Inc. has appointed Jeremiah A. Sparks as chief commercialization officer. Spectral AI focuses on medical diagnostics for faster and more accurate treatment decisions in wound care....
MORE►
by Lance Murray |
Apr 26, 2024
The largest investor in Spectral AI, Erich Spangenberg, has extensive expertise in intellectual property investment management.
MORE►
Spectral AI has named Peter M. Carlson as CEO. [Photo: LInkedIn]
Spectral AI Names Former Top MiMedx Financial Exec as CFO
by Lance Murray | Dec 27, 2023
Seasoned financial executive Peter M. Carlson has been hired as chief financial officer of Dallas-based Spectral AI Inc., an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care.
Carlson will succeed Nils Windler, who will remain with Spectral AI to work closely with Carlson, support an orderly transition of responsibilities, and provide financial accounting support to the company....
MORE►
by Lance Murray |
Dec 1, 2023
Dallas-based predictive artificial intelligence company Spectral AI Inc. announced that Erich Spangenberg has been appointed to the company’s board of directors and named chairman of its executive committee.
Spectral AI focuses on medical diagnostics for faster and more accurate treatment decisions in clinical wound care.
“We are pleased to welcome the return of Erich to the board of directors, where his experience, insights and network will be an invaluable resource for our company,” Spectral AI CEO Wensheng Fan said in a statement....
MORE►
by Lance Murray |
Oct 27, 2023
Spectral AI has recently secured its largest contract to date from the U.S. government, an award exceeding $149 million, boosting its total U.S. government awards accrued since 2019 to more than $246 million, as it aims to revolutionize wound care. The company's DeepView SnapShot Wound Imaging System, has received UK Conformity Assessed (UKCA) marking for use in the United Kingdom and has been classified as a Class 1 medical device by U.S. FDA.
MORE►
by Lance Murray |
Oct 6, 2023
In September, the firm began trading on Nasdaq and secured a BARDA Project BioShield contract worth up to $149 million.
MORE►
From left, Spectral MD CEO and Co-Founder Wensheng Fan and General Counsel Vince Capone. [Photos: Spectral MD]
Dallas’ Spectral MD Offers Updates in Run-Up to Its Nasdaq Listing as Spectral AI
by David Seeley | Aug 29, 2023
With $130 million in government funding supporting its AI-powered wound-prediction tech as a triage tool for burn victims in a mass casualty event, Dallas-based Spectral MD is nearing its listing on Nasdaq via a SPAC merger. Its listing as "Spectral AI" is slated for September 8 or 11, and the company offered updates on how it's going—revealing the nuts & bolts of how such transactions work.
MORE►
